share_log
Benzinga ·  Apr 29 10:24
PTC Therapeutics Shares Are Trading Higher After Morgan Stanley Upgraded the Stock From Underweight to Equal-Weight and Raised Its Price Target From $28 to $30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment